A new first-aid method of treating carbon monoxide poisoning could prevent brain damage in patients by delivering more oxygen to the brain than the standard treatment, according to a study by physicians at the Toronto General Hospital, University Health Network (UHN).
The study is published in the December issue of the U.S. based and peer-reviewed journal Annals of Emergency Medicine. The researchers, led by Dr. Josh Rucker, a Toronto General Hospital research fellow and resident in the Anesthesiology training program at the University of Toronto, studied 14 subjects who were exposed to low levels of carbon monoxide (resulting in blood levels about equal to those in heavy smokers) on two occasions in order to simulate conditions during carbon monoxide poisoning.
After each exposure, which lasted one hour, the participants were given one of two "test treatments": the standard treatment of 100% oxygen, or the new method consisting of a mixture of mostly oxygen and some carbon dioxide. Each participant received both test treatments in random order. Researchers then monitored the amount of oxygen in the blood and the blood flow to the brain during exposure to carbon monoxide and during the test treatments.
"These results are intriguing," said Dr. Fisher, an anesthesiologist at Toronto General Hospital, University Health Network, Associate Professor in the Faculty of Medicine at the University of Toronto and a senior author of the study. "Most doctors believe that giving patients oxygen is like giving them chicken soup -- it cant hurt. But, in fact, we find that treating carbon monoxide-exposed participants with pure oxygen actually limits the amount of oxygen that gets to their brains. That is worrisome."
"If severely poisoned patients respond like our test subjects, this new first-aid treatment may decrease the extent of brain damage in survivors," added Dr. Joseph Fisher.
CARBON MONOXIDE POISONING
The study was supported, in part, by the Department of Anesthesia, University Health Network and the University of Toronto, and the Tobi and Ted Bekhor Foundation.
The Toronto General Hospital is a partner in University Health Network, along with Toronto Western and Princess Margaret Hospitals. The scope of research and complexity of cases at Toronto General Hospital has made it a national and international source for discovery, education and patient care. It has one of the largest hospital-based research programs in Canada, with major research projects in cardiology, transplantation, surgical innovation, infectious diseases, and genomic medicine. Toronto General Hospital is a teaching hospital affiliated with the University of Toronto.
To schedule an interview with Dr. Josh Rucker or Dr. Joseph Fisher, please contact:
Toronto General Hospital, University Health Network
Marlene de Chellis | EurekAlert!
Study suggests possible new target for treating and preventing Alzheimer's
02.12.2016 | Oregon Health & Science University
The first analysis of Ewing's sarcoma methyloma opens doors to new treatments
01.12.2016 | IDIBELL-Bellvitge Biomedical Research Institute
A multi-institutional research collaboration has created a novel approach for fabricating three-dimensional micro-optics through the shape-defined formation of porous silicon (PSi), with broad impacts in integrated optoelectronics, imaging, and photovoltaics.
Working with colleagues at Stanford and The Dow Chemical Company, researchers at the University of Illinois at Urbana-Champaign fabricated 3-D birefringent...
In experiments with magnetic atoms conducted at extremely low temperatures, scientists have demonstrated a unique phase of matter: The atoms form a new type of quantum liquid or quantum droplet state. These so called quantum droplets may preserve their form in absence of external confinement because of quantum effects. The joint team of experimental physicists from Innsbruck and theoretical physicists from Hannover report on their findings in the journal Physical Review X.
“Our Quantum droplets are in the gas phase but they still drop like a rock,” explains experimental physicist Francesca Ferlaino when talking about the...
The Max Planck Institute for Physics (MPP) is opening up a new research field. A workshop from November 21 - 22, 2016 will mark the start of activities for an innovative axion experiment. Axions are still only purely hypothetical particles. Their detection could solve two fundamental problems in particle physics: What dark matter consists of and why it has not yet been possible to directly observe a CP violation for the strong interaction.
The “MADMAX” project is the MPP’s commitment to axion research. Axions are so far only a theoretical prediction and are difficult to detect: on the one hand,...
Broadband rotational spectroscopy unravels structural reshaping of isolated molecules in the gas phase to accommodate water
In two recent publications in the Journal of Chemical Physics and in the Journal of Physical Chemistry Letters, researchers around Melanie Schnell from the Max...
The efficiency of power electronic systems is not solely dependent on electrical efficiency but also on weight, for example, in mobile systems. When the weight of relevant components and devices in airplanes, for instance, is reduced, fuel savings can be achieved and correspondingly greenhouse gas emissions decreased. New materials and components based on gallium nitride (GaN) can help to reduce weight and increase the efficiency. With these new materials, power electronic switches can be operated at higher switching frequency, resulting in higher power density and lower material costs.
Researchers at the Fraunhofer Institute for Solar Energy Systems ISE together with partners have investigated how these materials can be used to make power...
16.11.2016 | Event News
01.11.2016 | Event News
14.10.2016 | Event News
02.12.2016 | Medical Engineering
02.12.2016 | Agricultural and Forestry Science
02.12.2016 | Physics and Astronomy